1. Home
  2. CLWT vs BRTX Comparison

CLWT vs BRTX Comparison

Compare CLWT & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CLWT

Euro Tech Holdings Company Limited

N/A

Current Price

$1.23

Market Cap

9.4M

ML Signal

N/A

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$1.13

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLWT
BRTX
Founded
1971
1997
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Professional and commerical equipment
Managed Health Care
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.4M
9.7M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
CLWT
BRTX
Price
$1.23
$1.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
151.3K
80.8K
Earning Date
12-29-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$15,383,000.00
$383,400.00
Revenue This Year
N/A
$112.14
Revenue Next Year
N/A
$139.81
P/E Ratio
$12.41
N/A
Revenue Growth
N/A
1.70
52 Week Low
$0.99
$0.98
52 Week High
$1.63
$2.55

Technical Indicators

Market Signals
Indicator
CLWT
BRTX
Relative Strength Index (RSI) 62.30 41.90
Support Level $1.14 $1.00
Resistance Level $1.24 $1.16
Average True Range (ATR) 0.07 0.08
MACD 0.02 0.02
Stochastic Oscillator 95.87 73.10

Price Performance

Historical Comparison
CLWT
BRTX

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: